These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 32194573)

  • 1. Checkpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic HBV Infection.
    Hoogeveen RC; Boonstra A
    Front Immunol; 2020; 11():401. PubMed ID: 32194573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Highly Attenuated Vesicular Stomatitis Virus-Based Vaccine Platform Controls Hepatitis B Virus Replication in Mouse Models of Hepatitis B.
    Moshkani S; Chiale C; Lang SM; Rose JK; Robek MD
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.
    Meng Z; Chen Y; Lu M
    Front Immunol; 2019; 10():3127. PubMed ID: 32117201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy and therapeutic vaccines for chronic HBV infection.
    Lang-Meli J; Neumann-Haefelin C; Thimme R
    Curr Opin Virol; 2021 Dec; 51():149-157. PubMed ID: 34710645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice.
    Michler T; Kosinska AD; Festag J; Bunse T; Su J; Ringelhan M; Imhof H; Grimm D; Steiger K; Mogler C; Heikenwalder M; Michel ML; Guzman CA; Milstein S; Sepp-Lorenzino L; Knolle P; Protzer U
    Gastroenterology; 2020 May; 158(6):1762-1775.e9. PubMed ID: 32001321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
    Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
    J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients.
    Dou Y; Jansen DTSL; van den Bosch A; de Man RA; van Montfoort N; Araman C; van Kasteren SI; Zom GG; Krebber WJ; Melief CJM; Woltman AM; Buschow SI
    Antiviral Res; 2020 Jun; 178():104746. PubMed ID: 32081741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic HBV vaccine drives immune responses in liver.
    Hum Vaccin Immunother; 2013 Jan; 9(1):7-8. PubMed ID: 23570047
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody-mediated immunotherapy against chronic hepatitis B virus infection.
    Gao Y; Zhang TY; Yuan Q; Xia NS
    Hum Vaccin Immunother; 2017 Aug; 13(8):1768-1773. PubMed ID: 28521640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes.
    Godon O; Evlachev A; Bourgine M; Meritet JF; Martin P; Inchauspe G; Michel ML
    Vaccine; 2015 Aug; 33(36):4548-53. PubMed ID: 26209840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic vaccination for treatment of chronic hepatitis B.
    Cargill T; Barnes E
    Clin Exp Immunol; 2021 Aug; 205(2):106-118. PubMed ID: 33969474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges.
    Michel ML; Deng Q; Mancini-Bourgine M
    J Hepatol; 2011 Jun; 54(6):1286-96. PubMed ID: 21238516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic vaccination against chronic hepatitis B virus infection.
    Michel ML; Mancini-Bourgine M
    J Clin Virol; 2005 Dec; 34 Suppl 1():S108-14. PubMed ID: 16461209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in therapeutics for chronic hepatitis B.
    Yang N; Bertoletti A
    Hepatol Int; 2016 Mar; 10(2):277-85. PubMed ID: 26363922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?
    Koh S; Bertoletti A
    Med Microbiol Immunol; 2015 Feb; 204(1):87-94. PubMed ID: 25511870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic vaccination against chronic hepatitis B virus infection].
    Mancini-Bourgine M; Michel ML
    Therapie; 2005; 60(3):257-65. PubMed ID: 16128268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches.
    Fisicaro P; Barili V; Rossi M; Montali I; Vecchi A; Acerbi G; Laccabue D; Zecca A; Penna A; Missale G; Ferrari C; Boni C
    Front Immunol; 2020; 11():849. PubMed ID: 32477347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection.
    Lau GK
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E46-52. PubMed ID: 10921382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological cure of HBV infection.
    Lang J; Neumann-Haefelin C; Thimme R
    Hepatol Int; 2019 Mar; 13(2):113-124. PubMed ID: 30600480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for Chronic Hepatitis B Virus Infection.
    Bertoletti A; Le Bert N
    Gut Liver; 2018 Sep; 12(5):497-507. PubMed ID: 29316747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.